Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia.

Grant PM, Beck AT.

Schizophr Bull. 2009 Jul;35(4):798-806. doi: 10.1093/schbul/sbn008.

2.

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.

Jabben N, Arts B, van Os J, Krabbendam L.

J Clin Psychiatry. 2010 Jun;71(6):764-74. doi: 10.4088/JCP.08m04837yel.

PMID:
20122370
3.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. French.

PMID:
19081451
4.

A social path to functioning in schizophrenia: From social self-efficacy through negative symptoms to social functional capacity.

Vaskinn A, Ventura J, Andreassen OA, Melle I, Sundet K.

Psychiatry Res. 2015 Aug 30;228(3):803-7. doi: 10.1016/j.psychres.2015.05.019.

PMID:
26089018
5.

Asocial beliefs as predictors of asocial behavior in schizophrenia.

Grant PM, Beck AT.

Psychiatry Res. 2010 May 15;177(1-2):65-70. doi: 10.1016/j.psychres.2010.01.005.

PMID:
20163875
6.

Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.

Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC.

Psychiatry Res. 2008 May 30;159(1-2):140-6. doi: 10.1016/j.psychres.2007.10.012.

PMID:
18423611
7.

Evaluation sensitivity as a moderator of communication disorder in schizophrenia.

Grant PM, Beck AT.

Psychol Med. 2009 Jul;39(7):1211-9. doi: 10.1017/S0033291709005479.

PMID:
19379529
8.

Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.

Brissos S, Dias VV, Carita AI, Martinez-Arán A.

Psychiatry Res. 2008 Jul 15;160(1):55-62. doi: 10.1016/j.psychres.2007.04.010.

PMID:
18485488
9.

Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.

Chang WC, Ming Hui CL, Yan Wong GH, Wa Chan SK, Ming Lee EH, Hai Chen EY.

J Clin Psychiatry. 2013 Nov;74(11):e1046-53. doi: 10.4088/JCP.13m08355.

PMID:
24330905
10.

Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.

Savilla K, Kettler L, Galletly C.

Aust N Z J Psychiatry. 2008 Jun;42(6):496-504. doi: 10.1080/00048670802050512.

PMID:
18465376
11.

Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients.

Bellino S, Rocca P, Patria L, Marchiaro L, Rasetti R, Di Lorenzo R, Paradiso E, Bogetto F.

J Clin Psychiatry. 2004 Jul;65(7):908-14.

PMID:
15291678
12.

Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.

Bozikas VP, Kosmidis MH, Giannakou M, Anezoulaki D, Petrikis P, Fokas K, Karavatos A.

J Nerv Ment Dis. 2007 Apr;195(4):325-31.

PMID:
17435483
13.

Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

Kao YC, Liu YP.

BMC Psychiatry. 2010 Aug 18;10:63. doi: 10.1186/1471-244X-10-63.

14.

Psychological predictors of functional outcome in people with schizophrenia.

Kiwanuka JN, Strauss GP, McMahon RP, Gold JM.

Schizophr Res. 2014 Aug;157(1-3):299-304. doi: 10.1016/j.schres.2014.04.030.

15.

Dissociating self-reported cognitive complaint from clinical insight in schizophrenia.

Bayard S, Capdevielle D, Boulenger JP, Raffard S.

Eur Psychiatry. 2009 May;24(4):251-8. doi: 10.1016/j.eurpsy.2008.12.010.

PMID:
19324531
16.

Illness-related components for the family burden of relatives to patients with psychotic illness.

Hjärthag F, Helldin L, Karilampi U, Norlander T.

Soc Psychiatry Psychiatr Epidemiol. 2010 Feb;45(2):275-83. doi: 10.1007/s00127-009-0065-x.

PMID:
19452109
17.
18.

Insight dimensions and cognitive function in psychosis: a longitudinal study.

Cuesta MJ, Peralta V, Zarzuela A, Zandio M.

BMC Psychiatry. 2006 May 31;6:26.

19.

The MIRECC version of the Global Assessment of Functioning scale: reliability and validity.

Niv N, Cohen AN, Sullivan G, Young AS.

Psychiatr Serv. 2007 Apr;58(4):529-35.

PMID:
17412856
20.

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.

de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F.

Psychiatry Res. 2013 Dec 15;210(2):387-95. doi: 10.1016/j.psychres.2013.06.042.

PMID:
23910239
Items per page

Supplemental Content

Support Center